n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide and cocaine
n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide has been researched along with cocaine in 3 studies
Compound Research Comparison
Studies (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Trials (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Recent Studies (post-2010) (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Studies (cocaine) | Trials (cocaine) | Recent Studies (post-2010) (cocaine) |
---|---|---|---|---|---|
14 | 0 | 0 | 32,461 | 1,096 | 9,400 |
Protein Interaction Comparison
Protein | Taxonomy | n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide (IC50) | cocaine (IC50) |
---|---|---|---|
Amyloid-beta precursor protein | Homo sapiens (human) | 0.338 | |
Fatty acid-binding protein, heart | Homo sapiens (human) | 0.367 | |
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0855 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0855 | |
D | Rattus norvegicus (Norway rat) | 5.7544 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.7544 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 5.7544 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.7544 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.2861 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.4321 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0855 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.5442 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.8885 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.3796 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 5.541 | |
Sodium-dependent dopamine transporter | Mus musculus (house mouse) | 0.2 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.05 | |
Transporter | Rattus norvegicus (Norway rat) | 3.2277 |
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Spealman, RD | 1 |
Koob, GF; Pulvirenti, L; Smith, D | 1 |
Deroche, V; Koob, GF; Weiss, F; Weissenborn, R | 1 |
Other Studies
3 other study(ies) available for n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide and cocaine
Article | Year |
---|---|
Discriminative stimulus effects of cocaine in squirrel monkeys: lack of antagonism by the dopamine D2 partial agonists terguride, SDZ 208-911, and SDZ 208-912.
Topics: Animals; Cocaine; Discrimination, Psychological; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Lisuride; Male; Receptors, Dopamine D2; Saimiri | 1995 |
SDZ 208-911, an amino-ergoline with partial dopamine agonist properties, dose dependently increases cocaine self-administration in the rat.
Topics: Animals; Cocaine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Male; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration | 1994 |
Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus.
Topics: Animals; Benzazepines; Bromocriptine; Cocaine; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Male; Raclopride; Rats; Rats, Wistar; Reinforcement, Psychology; Salicylamides; Self Administration | 1996 |